» Articles » PMID: 37626851

The Role of C-Abl Tyrosine Kinase in Brain and Its Pathologies

Overview
Journal Cells
Publisher MDPI
Date 2023 Aug 26
PMID 37626851
Authors
Affiliations
Soon will be listed here.
Abstract

Differentiated status, low regenerative capacity and complex signaling make neuronal tissues highly susceptible to translating an imbalance in cell homeostasis into cell death. The high rate of neurodegenerative diseases in the elderly population confirms this. The multiple and divergent signaling cascades downstream of the various stress triggers challenge researchers to identify the central components of the stress-induced signaling pathways that cause neurodegeneration. Because of their critical role in cell homeostasis, kinases have emerged as one of the key regulators. Among kinases, non-receptor tyrosine kinase (Abelson kinase) c-Abl appears to be involved in both the normal development of neural tissue and the development of neurodegenerative pathologies when abnormally expressed or activated. However, exactly how c-Abl mediates the progression of neurodegeneration remains largely unexplored. Here, we summarize recent findings on the involvement of c-Abl in normal and abnormal processes in nervous tissue, focusing on neurons, astrocytes and microglial cells, with particular reference to molecular events at the interface between stress signaling, DNA damage, and metabolic regulation. Because inhibition of c-Abl has neuroprotective effects and can prevent neuronal death, we believe that an integrated view of c-Abl signaling in neurodegeneration could lead to significantly improved treatment of the disease.

Citing Articles

Nilotinib as a Prospective Treatment for Alzheimer's Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis.

Srivastava A, Renna H, Johnson M, Sheehan K, Ahmed S, Palaia T Life (Basel). 2024; 14(10).

PMID: 39459541 PMC: 11509617. DOI: 10.3390/life14101241.


Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes.

Stevenson M, Algarzae N, Moussa C Front Dement. 2024; 3:1458038.

PMID: 39221072 PMC: 11361951. DOI: 10.3389/frdem.2024.1458038.


The c-Abl-RACK1-FAK signaling axis promotes renal fibrosis in mice through regulating fibroblast-myofibroblast transition.

Bao Q, Wang A, Hong W, Wang Y, Li B, He L Cell Commun Signal. 2024; 22(1):247.

PMID: 38689280 PMC: 11059681. DOI: 10.1186/s12964-024-01603-z.


Prophylactic treatment with the c-Abl inhibitor, neurotinib, diminishes neuronal damage and the convulsive state in pilocarpine-induced mice.

Chandia-Cristi A, Gutierrez D, Dulcey A, Lara M, Vargas L, Lin Y Cell Rep. 2024; 43(5):114144.

PMID: 38656874 PMC: 11230136. DOI: 10.1016/j.celrep.2024.114144.


Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.

Ratan Y, Rajput A, Pareek A, Pareek A, Jain V, Sonia S Biomolecules. 2024; 14(1).

PMID: 38254673 PMC: 10813470. DOI: 10.3390/biom14010073.


References
1.
Ait-Bouziad N, Chiki A, Limorenko G, Xiao S, Eliezer D, Lashuel H . Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau. J Biol Chem. 2020; 295(23):7905-7922. PMC: 7278352. DOI: 10.1074/jbc.RA119.012517. View

2.
Karim M, Liao E, Kim J, Meints J, Martinez H, Pletnikova O . α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment. Mol Neurodegener. 2020; 15(1):27. PMC: 7164361. DOI: 10.1186/s13024-020-00364-w. View

3.
Wang J, Ki S . Choosing between growth arrest and apoptosis through the retinoblastoma tumour suppressor protein, Abl and p73. Biochem Soc Trans. 2001; 29(Pt 6):666-73. DOI: 10.1042/0300-5127:0290666. View

4.
Wang T, Cleary R, Wang R, Tang D . Role of the adapter protein Abi1 in actin-associated signaling and smooth muscle contraction. J Biol Chem. 2013; 288(28):20713-22. PMC: 3711334. DOI: 10.1074/jbc.M112.439877. View

5.
Brahmachari S, Karuppagounder S, Ge P, Lee S, Dawson V, Dawson T . c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential. J Parkinsons Dis. 2017; 7(4):589-601. PMC: 5676866. DOI: 10.3233/JPD-171191. View